ASX:ACWActinogen Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Actinogen Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$0.02 0.00 (0.00 %) (As of 05/13/2020) Add Compare Share Today's RangeA$0.02Now: A$0.02▼A$0.0250-Day RangeA$0.02MA: A$0.02▼A$0.0252-Week RangeA$0.01Now: A$0.02▼A$0.07Volume275,000 shsAverage VolumeN/AMarket Capitalization$21.21 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Actinogen Medical Limited, a biotechnology company, develops treatments for Alzheimer's disease, and the cognitive deficiency associated with other neurological and metabolic diseases in Australia. It is developing Xanamem, a therapy for Alzheimer's disease; and XanADu, a Phase II double-blind, 12-week, randomized, placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's disease. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited is based in Sydney, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Actinogen Medical. Previous Next 2.4 Community Rank Outperform VotesActinogen Medical has received 15 “outperform” votes. (Add your “outperform” vote.)Underperform VotesActinogen Medical has received 16 “underperform” votes. (Add your “underperform” vote.)Community SentimentActinogen Medical has received 51.61% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Actinogen Medical and other stocks. Vote “Outperform” if you believe ACW will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACW will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldActinogen Medical does not currently pay a dividend.Dividend GrowthActinogen Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Actinogen Medical insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Actinogen Medical is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Actinogen Medical is -3.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioActinogen Medical has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:ACW Previous Symbol CUSIPN/A CIKN/A Webwww.actinogen.com.au Phone61 2 8964 7401Debt Debt-to-Equity Ratio3.56 Current Ratio11.42 Quick Ratio11.39Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.73 million Price / Sales3.70 Cash FlowA$0.01 per share Price / Cash Flow2.38 Book ValueA$0.01 per share Price / Book1.73Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares1,116,230,016Market Cap$21.21 million Next Earnings DateN/A OptionableNot Optionable Receive ACW News and Ratings via Email Sign-up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter. Actinogen Medical (ASX:ACW) Frequently Asked Questions How has Actinogen Medical's stock been impacted by COVID-19 (Coronavirus)? Actinogen Medical's stock was trading at A$0.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ACW shares have decreased by 13.6% and is now trading at A$0.02. View which stocks have been most impacted by Coronavirus. Has Actinogen Medical been receiving favorable news coverage? News stories about ACW stock have been trending very positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Actinogen Medical earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the next several days. View the latest news aboutActinogen Medical. Who are some of Actinogen Medical's key competitors? Some companies that are related to Actinogen Medical include Ampio Pharmaceuticals (AMPE), Actinium Pharmaceuticals (ATNM), Biopharmx (BPMX), Orthocell (OCC), Cynata Therapeutics (CYP), Oxford Biodynamics (OBD), Pediapharm (PDP), Biotron (BIT), Synairgen (SNG), 4d Pharma (DDDD), Navidea Biopharmaceuticals (NAVB), Equillium (EQ), Sirona Biochem (SBM), Immutep (IMM) and e-Therapeutics (ETX). View all competitors. Who are Actinogen Medical's key executives? Actinogen Medical's management team includes the following people: Dr. John William Ketelbey MBBCH, FFPM, MBA, GAICD, MD, CEO & DirectorMr. Peter G. Webse B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 56)Mr. Vincent Ruffles, VP of Drug Devel. What is Actinogen Medical's stock symbol? Actinogen Medical trades on the ASX under the ticker symbol "ACW." What is Actinogen Medical's stock price today? One share of ACW stock can currently be purchased for approximately A$0.02. How big of a company is Actinogen Medical? Actinogen Medical has a market capitalization of $21.21 million and generates $5.73 million in revenue each year. What is Actinogen Medical's official website? The official website for Actinogen Medical is www.actinogen.com.au. How can I contact Actinogen Medical? The company can be reached via phone at 61 2 8964 7401. This page was last updated on 6/5/2020 by MarketBeat.com Staff
